buyWeak
CTT PHARMACEUTICAL HOLDINGS, INC. bought $776 of CTTH
CEO at CTT PHARMACEUTICAL HOLDINGS, INC.. 15,510 shares at an average of $0.05, traded Mar 31, 2025, filed Mar 31, 2025.
Conviction score
25Value
$776
15,510 shares
Holdings after
6,590,416
+0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001035422-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | POpen-market purchase CTTH | +15,510 | $0.05 | $776 | 6,590,416 | Mar 31, 2025 |
Related signals
Other insiders at CTT PHARMACEUTICAL HOLDINGS, INC. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 25Weak | buy | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | $324 | 5,400 | |
| 25Weak | buy | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | $1,076 | 11,950 | |
| 25Weak | buy | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | $624 | 5,200 | |
| 20Weak | buy | CTTH CTT PHARMACEUTICAL HOLDINGS, INC. | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | $1,401 | 23,346 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.